CSL Limited (CSJ.F)

167,58 +0,68 (+0,41%) Börsenschluss: 09:41PM CEST

CSL Limited

655 Elizabeth Street
Melbourne, VIC 3000
Australia
61 3 9389 1911
https://www.csl.com.au

Sektor(en): Healthcare
Branche: Biotechnology
Vollzeitmitarbeiter: 32.065

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Dr. Paul F. McKenzie Ph.D.	MD, CEO & Executive Director	2,57M	N/A	1966
Ms. Joy Carolyn Linton B.Com., BComm, GAICD, Grad Dip AFI	Chief Financial Officer	1,91M	N/A	1965
Mr. Mark Dehring	Head of Investor Relations	N/A	N/A	N/A
Mr. Gregory Boss B.S., BS(Hons), J.D.	Executive VP of Legal & General Counsel	1,02M	N/A	1961
Christina Hickie	Senior Manager of Communications	N/A	N/A	N/A
Ms. Roanne Parry	Chief Human Resources Officer	N/A	N/A	N/A
Dr. Karen Etchberger	Executive Vice President of Quality & Business Services	960,73k	N/A	1958
Ms. Jemimah Brennan	Head of Communications - Asia Pacific	N/A	N/A	N/A
Dr. Andrew D. Nash BSc (Hons), GAICD, Ph.D.	Senior Vice President of Research	N/A	N/A	1962
Dr. William Mezzanotte M.D., M.P.H.	Executive VP & Head of Research and Development	1,36M	N/A	1959

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in EUR.

Beschreibung

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants. The CSL Seqirus segment provides influenza related products and pandemic services to governments. The CSL Vifor segment offers products in the therapeutic areas of iron deficiency and nephrology. The company also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.

Corporate Governance

CSL Limiteds ISS Governance QualityScore, Stand 1. April 2024, lautet 2. Die grundlegenden Scores sind Audit: 4, Vorstand: 4, Shareholderrechte: 1, Kompensation: 4.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.